N-alkyl-N-nitrosourea induced secondary structural changes in DNA from rat embryos and fetal brains in vivo.
N-methyl-N-nitrosourea (MNU) and N-ethyl-N-nitrosourea (ENU) are gestational stage dependent teratogens and transplacental carcinogens capable of inducing neurogenic tumours in rats. Intravenous treatment of gravid Wistar rats showed that MNU is teratogenic but ENU is a transplacental carcinogen and may be a teratogen when administered on day 12 of gestation. Twenty-four hours after single doses of 2, 5, or 10 mg MNU/kg on day 12, dose dependent decreases in embryonic wet weight and total embryonic DNA were observed. Rats similarly treated with 2 and 5 mg MNU/kg showed dose dependent decreases in fetal brain DNA synthesis, DNA content, and wet weight 9 days later. Administration of single ENU doses of 1.5, 3, 6, 12, 48, and 80 mg/kg to day 12 embryos resulted in a dose dependent reduction in [methyl-14C]-thymidine (14C-TdR) incorporation into DNA after 24 h although total DNA amounts and embryonic wet weights were unaffected. Benzoylated DEAE-cellulose (BD-cellulose) chromatography fractionates DNA on the basis of secondary structure by stepwise elution of double-stranded DNA with 1.0 M NaCl solution (SE-DNA) followed by elution of DNA containing single-stranded regions with caffeine solution (CE-DNA). Day 13 embryonic and day 21 fetal brain DNA was monitored by in vivo labelling with [methyl-3H]-thymidine on days 6 and 7 of gestation. Significant reduction in percentages of CE-DNA (%CE-DNA) 24 h after treatment of day 12 embryos with 2, 5, or 10 mg MNU/kg were attributed to the necrotic effect of MNU. Day 12 treatment with MNU produced no change in %CE-DNA values of day 21 fetal brains. A teratogenic dose of 80 mg ENU/kg to day 12 embryos resulted in significantly increased %CE-DNA values compared to controls but no changes were observed after 1.5 to 48 mg/kg. Analysis of the distribution of %CE-DNA values from the 80 mg ENU/kg treated litter showed that the increase in %CE-DNA was due to a second distinct population of embryos with higher %CE-DNA values than controls. Incorporation of 14C-TdR into embryonic and fetal brain DNA demonstrated the effects of treatment with these compounds on DNA synthesis in vivo. The relative %CE-DNA is expressed as the ratio of the percentage of caffeine-eluted 14C-labelled DNA to %CE-DNA (i.e., %CE-14C-DNA:%CE-3H-DNA). In the majority of control embryos the 14C-specific activity of CE-DNA was higher than the 14C-specific activity of SE-DNA.(ABSTRACT TRUNCATED AT 400 WORDS)
Foundation 41, Molecular Biology Unit, Potts Point, New South Wales, Australia.
P H
PH
Huang
A
A
Catalano
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004247:DNA / Q000187:drug effects* / Q000378:metabolism; D004622:Embryo, Mammalian / Q000187:drug effects; D005038:Ethylnitrosourea / Q000633:toxicity*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D008770:Methylnitrosourea / Q000633:toxicity*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009690:Nucleic Acid Conformation / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar
D008770:Methylnitrosourea; D004247:DNA; D005038:Ethylnitrosourea